Teva's Biosimilar Boom Just Beginnings: Is It Time to Buy?
Teva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Index movements reflect changes in component stock prices, earnings, macro data, and capital flows. This overview highlights the main drivers behind daily swings.
18,176 articlesTeva is turning the corner with a growing biosimilars roster and improving margins. This article examines whether tev...
Oil-price volatility and strong cash-flow signals helped Occidental Petroleum stock jumped on Monday. Learn the drive...
Small AI plays can jump from obscurity to headlines fast. This guide analyzes the risks and potential rewards, with p...
Sandisk stock fell today after an upbeat start as investors weighed AI memory tech prospects against inflation jitter...
This in-depth guide analyzes docebo (dcbo) 2025 earnings, breaking down revenue growth, profitability, and strategic ...
Three under-the-radar high-yield ETFs are delivering higher income in a market where cash yields rise. This report br...
Stocks drift lower in mid-June 2026 as investors reassess AI and chip names. This guide lays out what look when buyin...
SMR stocks like NuScale Power and Oklo have dazzled investors, but 2026 could test whether execution, not hype, drive...
Ecopetrol sits at the crossroads of a volatile energy market and a growing emerging markets economy. This deep dive b...
Fox said it will acquire Roku in a $22 billion cash-and-stock deal, at $160 per Roku share. The transaction is slated...
As Ituran gears up for its 2025 earnings, investors want clarity on growth, margins, and cash flow. This guide breaks...
When Berkshire Hathaway named Greg Abel to lead investments, the portfolio made a surprising pivot. This article brea...